No particular news except Seeking Alpha has been
Post# of 54
(Total Views: 4381)
Posted On: 03/16/2017 3:36:59 PM
No particular news except Seeking Alpha
has been following it publicly on positive moves.
On the chart
it is moving in an orderly
fashion above the upper bollie.
$3.08
Premarket Gainers as of 9:10 am
SA News•Today, 9:20 AM•1 Comment
After Hours Gainers / Losers
SA News•Yesterday, 5:35 PM•1 Comment
Midday Gainers / Losers
SA News•Yesterday, 12:43 PM
Healthcare- Top 5 Gainers / Losers as of 12:15 PM
SA News•Yesterday, 12:15 PM
Cerulean up 44% in early trading
SA News•Yesterday, 10:46 AM•12 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Yesterday, 9:15 AM
Premarket Gainers / Losers as of 9:10 am
SA News•Tue, Mar. 14
Midday Gainers / Losers
SA News•Mon, Mar. 13•13 Comments
Healthcare - Top 5 Gainers / Losers as of 12:10 PM
SA News•Mon, Mar. 13•2 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Mar. 13•3 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Thu, Feb. 9•2 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Tue, Feb. 7•8 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Feb. 6•4 Comments
Cerulean Pharma receives deficiency notice from Nasdaq
SA News•Nov. 18, 2016•6 Comments
Cerulean Pharma Inc. SEC Filing - Current report (8-K) November 18, 2016
SEC Filings•Nov. 18, 2016
Other News
3 Reasons Why Cerulean Pharma (CERU) is a Great Momentum Stock
at Zacks.com (Jan 9, 2017)
Cerulean Announces Promotion Of Scott Eliasof, PhD To Senior Vice President And Chief Scientific Officer
at TheStreet (Oct 26, 2016)
First Week of June 2017 Options Trading For Cerulean Pharma (CERU)
at TheStreet (Oct 25, 2016)
Mid-Day Market Update: Crude Oil Up 2.75%; Cerulean Pharma Shares Surge On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Stock Shoots Higher On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Announces Technology Platform Collaboration
at TheStreet (Oct 19, 2016)
Cerulean Announces Data Presentations At The 2016 European Society For Medical Oncology Annual Meeting
at TheStreet (Oct 6, 2016)
Barclays Remains Positive On Cerulean Pharma Despite Failed Renal Cancer Trial
at Benzinga (Aug 30, 2016)
Cerulean Announces Reduction In Force
at TheStreet (Aug 18, 2016)
Cerulean Pharma (CERU) Stock Tumbles on Lead Kidney Cancer Drug Failure
at TheStreet (Aug 18, 2016)
< >
has been following it publicly on positive moves.
On the chart
it is moving in an orderly
fashion above the upper bollie.
$3.08
Premarket Gainers as of 9:10 am
SA News•Today, 9:20 AM•1 Comment
After Hours Gainers / Losers
SA News•Yesterday, 5:35 PM•1 Comment
Midday Gainers / Losers
SA News•Yesterday, 12:43 PM
Healthcare- Top 5 Gainers / Losers as of 12:15 PM
SA News•Yesterday, 12:15 PM
Cerulean up 44% in early trading
SA News•Yesterday, 10:46 AM•12 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Yesterday, 9:15 AM
Premarket Gainers / Losers as of 9:10 am
SA News•Tue, Mar. 14
Midday Gainers / Losers
SA News•Mon, Mar. 13•13 Comments
Healthcare - Top 5 Gainers / Losers as of 12:10 PM
SA News•Mon, Mar. 13•2 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Mar. 13•3 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Thu, Feb. 9•2 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Tue, Feb. 7•8 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Feb. 6•4 Comments
Cerulean Pharma receives deficiency notice from Nasdaq
SA News•Nov. 18, 2016•6 Comments
Cerulean Pharma Inc. SEC Filing - Current report (8-K) November 18, 2016
SEC Filings•Nov. 18, 2016
Other News
3 Reasons Why Cerulean Pharma (CERU) is a Great Momentum Stock
at Zacks.com (Jan 9, 2017)
Cerulean Announces Promotion Of Scott Eliasof, PhD To Senior Vice President And Chief Scientific Officer
at TheStreet (Oct 26, 2016)
First Week of June 2017 Options Trading For Cerulean Pharma (CERU)
at TheStreet (Oct 25, 2016)
Mid-Day Market Update: Crude Oil Up 2.75%; Cerulean Pharma Shares Surge On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Stock Shoots Higher On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Announces Technology Platform Collaboration
at TheStreet (Oct 19, 2016)
Cerulean Announces Data Presentations At The 2016 European Society For Medical Oncology Annual Meeting
at TheStreet (Oct 6, 2016)
Barclays Remains Positive On Cerulean Pharma Despite Failed Renal Cancer Trial
at Benzinga (Aug 30, 2016)
Cerulean Announces Reduction In Force
at TheStreet (Aug 18, 2016)
Cerulean Pharma (CERU) Stock Tumbles on Lead Kidney Cancer Drug Failure
at TheStreet (Aug 18, 2016)
< >
(0)
(0)Cerulean Pharma Inc. (DARE) Stock Research Links
Scroll down for more posts ▼